CWM
SUPN icon

CIBC World Markets’s Supernus Pharmaceuticals SUPN Stock Holding History

CIBC World Markets’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$210K Sell
6,648
-4,495
-40% -$144K ﹤0.01% 1266
2025
Q1 		$365K Buy
+11,143
New +$395K ﹤0.01% 1162

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CIBC World Markets's SUPN Position: Q2 2025 in Review

CIBC World Markets reduced its Supernus Pharmaceuticals (SUPN) stake by 40% in Q2 2025, selling an estimated $144K and leaving 6,648 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

CIBC World Markets first reported a position in SUPN in Q1 2025 and has held it in 2 quarters since. The position peaked at $365K in Q1 2025. 295 funds tracked by Wall St. Rank hold SUPN as of Q2 2025.

  • CIBC World Markets held 6,648 shares of Supernus Pharmaceuticals worth $210K as of Q2 2025.
  • CIBC World Markets sold 4,495 Supernus Pharmaceuticals shares in Q2 2025, an estimated $144K.
  • Supernus Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1266 holding.
  • CIBC World Markets first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Supernus Pharmaceuticals position peaked at $365K in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.